Sarcoma incidence and subtype distribution in Israel – A population-based study. (February 2021)

• Record Type: Journal Article
• Authors: Icht, Oded; Lewin, Ron; Yosef, Lilach; Fichman, Suzana; Silverman, Barbara; Zer, Alona
• Is Part Of: Cancer epidemiology. Volume 70(2021)
• Publication Date: 2021-02
• Subjects: Sarcoma -- Kaposi sarcoma -- Sarcoma incidence -- Israel; Cancer -- Epidemiology -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Diagnosis -- Periodicals; Carcinogenesis -- Periodicals; 616.994005
• DOI: 10.1016/j.canep.2020.101876
• Languages: English
• ISSNs: 1877-7821

Abstract

Highlights: A population-based study describing sarcoma incidence in Israel. Concordance of 90 % between pathology coding and registry in the national database. Sarcoma incidence is 8/100 K persons, and has a downward trend in the past 2 decades. Kaposi sarcoma has the highest incidence – 1.6/100 K persons. Abstract: Introduction: This report aimed to describe sarcoma incidence and subtype distribution in Israel, as well as evaluate accuracy of registration for sarcoma cases diagnosed at a single institution. Methods: Incidence reports were issued for all sarcomas diagnosed between 1996–2017. Concordance between the WHO classification used in pathology reports and the diagnoses in the national registry were evaluated. Sarcoma subtype distribution was analysed. Results: Between 1996–2017 sarcomas had an annual percent change of −2.1 in men and −1.5 in women. Concordance between the pathology report coding and registry in the INCR were 90 %. The most common subtypes were Kaposi sarcoma (KS), liposarcoma and leiomyosarcoma accounting for 21 %, 14.4 % and 10.8 % of all sarcomas, respectively. KS had the highest incidence with 1.6/100, 000 persons. Conclusion: This is the first description of sarcoma incidence and subtype distribution in Israel. Sarcoma incidence in Israel has declined in the past two decades.